Avantor and Catalent have entered into a multi-year supply and services agreement. Avantor will be the primary supplier of a broad range of laboratory supplies, clinical and production materials, and services to Catalent, expanding the companies’ existing relationship.

“We have seen firsthand that Avantor is a terrific partner that brings diverse capabilities and expertise across modalities and geographies, which is essential to meeting global health needs,” said Alessandro Maselli, president and CEO, Catalent. “We look forward to deepening our work with the Avantor team to bring current and novel treatments to patients around the world.”

Michael Stubblefield, resident and CEO, Avantor, said, “Catalent has built tremendous global capabilities and a reputation as a trusted collaborator to pharma, biotech and consumer health partners throughout the development and production lifecycle. We are pleased to expand our support for Catalent and enable efficiencies to accelerate science for their customers around the globe.”